A significant discovery in cancer study is emerging with the use of VHH fragments to re-engage mutated p53. This vital malignant protector protein is frequently disabled in several forms of tumors, causing uncontrolled https://allbookmarking.com/story22089939/mini-antibodies-revive-p53-the-potential-pathway-for-tumor-treatment